Bulk materials to be registered during approval process for finished drugs.

Having learned from the bitter experience with Ferritin incidence the KFDA plans to intensify drug quality controls over the whole processes from the production and purchasing of bulk materials to the manufacture of finished drugs.
The KFDA concluded that the quality of finished drugs be well established by means of KGMP set-up to a certain up-level but of raw materials still remained far beh...